Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facility and Holding in Company

25 Jan 2024 07:00

RNS Number : 8369A
Location Sciences Group PLC
25 January 2024
 

25 January 2024

 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Location Sciences Group PLC

("Location Sciences" or the "Company" or the "Group")

 

Term loan facility entered into with Bidco 3 Limited

and

Holding in Company

 

Location Sciences (AIM: LSAI) announces that the Company has entered into an unsecured term loan facility agreement with Bidco 3 Limited (the "Lender" or "Bidco 3") for a total principal amount of up to £3.0 million (the "Facility"). Bidco 3 is a special purpose holding company focused on making appropriate strategic investments.

 

Background to and reasons for the Facility

 

As most recently announced by the Company on 20 December 2023, a considerable amount of work has been carried out in relation to the Company's proposed acquisition of the entire issued share capital of Sorted Holdings Limited ("Sorted") (the "Proposed Acquisition"). As the Company continues to work towards the finalisation of the Proposed Acquisition, the Company is cognisant of its existing overheads and working capital requirements, and those of the Company following completion of the Proposed Acquisition. In this respect, the Facility, subject to the satisfaction of certain customary conditions precedent, will be available for drawdown to be used for, inter alia, providing the Company with general working capital.

 

Key terms and conditions of the Facility

 

The Company may utilise the Facility in one or more tranches, provided that any utilisation of the Facility is for a minimum amount of £0.5 million, with the aggregate amount of funds drawn pursuant to the Facility not exceeding £3.0 million.

 

Borrowings under the Facility will accrue interest daily at 1.5 per cent. per month and shall be repayable on 31 January 2026. The Facility is subject to customary events of default and an arrangement fee of £125,000 is payable to the Lender, which can be satisfied in cash or by the issuance of ordinary shares in the Company at the Lender's option.

 

Holding in Company

 

Separate to the above, Location Sciences was informed on 24 January 2024 that Daron Lee now holds 75,000,000 ordinary shares in the Company, representing approximately 2.83 per cent of the issued share capital of the Company.

 

For further information please contact:

 

Location Sciences Group PLC via Allenby Capital

Simon Wilkinson, Chairman

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

Vivek Bhardwaj

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEUEELELSEEF
Date   Source Headline
9th Jul 20123:54 pmRNSPosting of Circular
4th Jul 20123:00 pmRNSSubscription in Praetorian Resources
8th Jun 201211:00 amRNSResult of AGM
15th May 20127:00 amRNSNotice of AGM
13th Apr 20123:58 pmRNSAnnual Financial Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
27th Oct 20113:48 pmRNSDirector/PDMR Shareholding
15th Sep 201111:14 amRNSInterim Results
7th Sep 20113:29 pmRNSHolding(s) in Company
29th Jul 201111:15 amRNSResult of AGM
28th Jul 201111:21 amRNSHolding(s) in Company
17th Jun 20118:00 amRNSNotice of AGM
1st Apr 20117:00 amRNSChange of Adviser
28th Mar 20112:17 pmRNSFinal Results
23rd Sep 20102:51 pmRNSInterim Results
27th Jul 20105:15 pmRNSDirectorate Change
21st Jul 20102:35 pmRNSHolding(s) in Company
21st Jul 20108:59 amRNSHolding(s) in Company
20th Jul 20104:40 pmRNSHolding(s) in Company
20th Jul 20104:39 pmRNSHolding(s) in Company
29th Jun 201011:40 amRNSResult of AGM
27th May 201012:51 pmRNSNotice of AGM
27th May 20107:00 amRNSAnnual Results for 31st December 2009
1st Apr 201011:22 amRNSDirector/PDMR Shareholding
19th Feb 20103:36 pmRNSDirector/PDMR Shareholding
16th Dec 200911:09 amRNSHolding(s) in Company
16th Dec 200911:05 amRNSHolding(s) in Company
5th Aug 200912:39 pmRNSInterim Results
8th Jun 200911:09 amRNSResult of AGM
15th May 20097:00 amRNSNotice of AGM
12th May 200911:17 amRNSFinal Results and Annual Financial Report
4th Mar 20093:23 pmRNSHolding(s) in Company
3rd Feb 20095:07 pmRNSHolding(s) in Company
8th Sep 20085:00 pmRNSInterim Results
21st Apr 20087:00 amRNSAdmission to Trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.